Daniel Fraughen
0000-0001-9876-4938
9 papers found
Refreshing results…
Reply to Chan: Identification of Alpha-1 Antitrypsin–Deficient Subjects with Normal Spirometry Who May Benefit from Alpha-1 Antitrypsin Replacement
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline—A Multinational Registry Analysis
Alpha-1 Antitrypsin Deficiency and Smoking Cessation
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19
Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin Deficiency
Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial
Irish Thoracic Society Annual Scientific Meeting 2020
To assess the appropriateness and quality of requests for CT Pulmonary Angiography to outrule pulmonary embolus in a tertiary referral centre in Ireland during a one month period.
Missing publications? Search for publications with a matching author name.